Latest News and Press Releases
Want to stay updated on the latest news?
-
SNIPR Biome today announced the close of a EUR 35 million Series B financing round addressing antimicrobial resistance and infectious disease.
-
SNIPR BIOME today announced that the first patient has been dosed in its Phase 1b study of SNIPR001 in patients with hematological cancer.